Skip to main content
TipRanks
Go Ultimate75% OFF

Medicskin Holdings Ltd. (8307) Stock Price & Analysis

1 Followers

8307 Stock Chart & Stats

HK$0.15HK$0.00(0.00%)
At close: 4:00 PM GMT+8
HK$0.1HK$0.125HK$0.15HK$0.175Sep 14Sep 29Oct 12Oct 26Nov 9
Day’s Range
HKD 0.15 - HKD 0.15
52-Week Range
HKD 0.02 - HKD 0.21
Previous Close
HKD 0.15
Volume
N/A
Average Volume (3M)
128.93K
Market Cap
HKD 59.51M
Enterprise Value
HKD 47.63M
Total Cash (Recent Filing)
HKD 29.46M
Total Debt (Recent Filing)
HKD 17.57M
Price to Earnings (P/E)
63.4
Beta
0.23
Next Earnings
Nov 16, 2026 (Est.)
EPS Estimate
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Consistent Cash Generation

Consistently positive operating and free cash flow gives the company an internal funding source for ongoing operations and reduces reliance on external financing. Although FY2026 free cash flow weakened, continued cash generation provides a durable liquidity base over the next several quarters.

Return To Profitability

Returning to positive net income after losses in FY2023–FY2025 indicates some recovery in earnings performance. If maintained, even modest profitability can support retained cash generation, improve financial resilience, and provide a base for rebuilding shareholder value.

Positive EBITDA Margins

Positive mid-teen EBITDA margins across four fiscal years show that the underlying operating model has continued to generate earnings before non-operating charges. This provides evidence of ongoing operating viability despite weak revenue and inconsistent bottom-line profitability.

Bears Say

Elevated Leverage

Leverage remains materially above the company’s earlier levels, while equity is small relative to the asset base. This reduces financial flexibility, increases sensitivity to weaker operating performance, and may constrain investment or cash allocation over the next several quarters.

Weak Revenue Trend

The recent revenue contraction and preceding decline indicate that growth has not been dependable. Sustained top-line weakness can reduce operating leverage, limit reinvestment capacity, and make it harder for the company to convert positive EBITDA into durable net profit.

Gross Margin Deterioration

The sharp gross-margin deterioration points to weaker earnings quality and less room to absorb operating costs. Unless margins stabilize, the company may remain vulnerable to further profit compression, particularly because FY2026 net margin was only approximately 2%.

8307 FAQ

What was Medicskin Holdings Ltd.’s price range in the past 12 months?
Medicskin Holdings Ltd. lowest stock price was HK$0.02 and its highest was HK$0.21 in the past 12 months.
What is Medicskin Holdings Ltd.’s market cap?
Medicskin Holdings Ltd.’s market cap is HK$59.51M.
When is Medicskin Holdings Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Medicskin Holdings Ltd.’s earnings last quarter?
Medicskin Holdings Ltd. released its earnings results on Jun 22, 2026. The company reported HK$0.002 earnings per share for the quarter.
Is Medicskin Holdings Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Medicskin Holdings Ltd. pay dividends?
Medicskin Holdings Ltd. pays a dividend of HK$0.025 which represents an annual dividend yield of ―. See more information on Medicskin Holdings Ltd. dividends here
What is Medicskin Holdings Ltd.’s EPS estimate?
Medicskin Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medicskin Holdings Ltd. have?
Medicskin Holdings Ltd. has 396,736,000 shares outstanding.
What happened to Medicskin Holdings Ltd.’s price movement after its last earnings report?
Medicskin Holdings Ltd. reported an EPS of HK$0.002 in its last earnings report. Following the earnings report the stock price went up 22.549%.
Which hedge fund is a major shareholder of Medicskin Holdings Ltd.?
Currently, no hedge funds are holding shares in HK:8307
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology